← Leaderboards
Matthew Becker
University Of Florida
$556,478
Attributed
$1,013,412
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $913.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,013,412 · 2
By mechanism
R44$913,868 · 1
F31$99,544 · 1
Top collaborators
- Norma Sue Kenyon1 shared
Most similar at University Of Florida
Same institution · by research overlap
- David R Borchelt$17,132,004
- Mary Jo Koroly$2,877,133
- Carl Atkinson$8,241,342
- Robert Paul Accolla$81,166
- Steven A Benner$25,054,107
Others in their field
Other Emerging Leaders on “Monitor”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Kimberly Smith · Ppd Development Lp$116,656,661
- Yunda Huang · Fred Hutchinson Cancer Center$71,488,059
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
MonitorAntigensDiabetes MellitusIn VivoPreventTechnologyCell TherapyComplexImmunosuppressionIn VitroPancreasAdultSafetySourceBiocompatible MaterialsCellsAmericanChildAffectImmuneInsulin-Dependent Diabetes MellitusBeta CellCell Adhesion MoleculesCd8-Positive T-Lymphocytes
Grant awards (4)
Hydrogel injection molded islet macroencapsulation devices to treat diabetes in a non-human primate model$913,868
R44 · FY2025 · DK · contact PI
Engineered tolerogenic exosomes for treating type 1 diabetes autoimmunity$20,652
F31 · FY2022 · DK · contact PI
Engineered tolerogenic exosomes for treating type 1 diabetes autoimmunity$39,704
F31 · FY2021 · DK · contact PI
Engineered tolerogenic exosomes for treating type 1 diabetes autoimmunity$39,188
F31 · FY2020 · DK · contact PI